Dexcom (DXCM) Capital Expenditures (2010 - 2026)
Dexcom (DXCM) posted quarterly Capital Expenditures of $84.7 million for Q2 2026, down 9.99% year-over-year from $94.1 million in Q2 2025, and up 10.57% quarter-over-quarter from $76.6 million in Q1 2026.
Dexcom (DXCM) Capital Expenditures (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Capital Expenditures for 17 consecutive years, with $84.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Capital Expenditures fell 9.99% year-over-year to $84.7 million; the TTM figure through Jun 2026 stood at $343.7 million (down 17.56% YoY), while the FY2025 annual figure was $363.5 million, up 1.31% from the prior year.
- Capital Expenditures grew to $84.7 million in Q2 2026 per DXCM's latest filing, from $76.6 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $124.6 million in Q4 2024 and bottomed at $50.4 million in Q3 2023.
- Historically, Capital Expenditures has averaged $82.5 million across 5 years, with a median of $82.6 million in 2025.
- Annual changes were most pronounced in 2023 — Capital Expenditures sank 53.42% — and 2024, when it soared 137.33%.
- Dexcom's Capital Expenditures stood at $63.5 million in 2022, then slipped by 17.32% to $52.5 million in 2023, then jumped by 137.33% to $124.6 million in 2024, then retreated by 18.22% to $101.9 million in 2025, then retreated by 16.88% to $84.7 million in 2026.
- Business Quant data shows DXCM's Capital Expenditures at $84.7 million in Q2 2026, $76.6 million in Q1 2026, and $101.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.38 Bn | 196.77 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 126.28 Bn | 122.80 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 74.10 Bn | 73.56 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.67 Bn | 47.42 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 35.07 Bn | 33.12 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.65 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.20 Bn | 22.88 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Zimmer Biomet Holdings | 19.28 Bn | 18.87 Bn | 1.54 Bn | 54.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 84.70 Mn |
| Jun 30, 2026 | 84.70 Mn |
| Mar 31, 2026 | 76.60 Mn |
| Mar 31, 2026 | 76.60 Mn |
| Dec 31, 2025 | 101.90 Mn |
| Dec 31, 2025 | 101.90 Mn |
| Sep 30, 2025 | 80.50 Mn |
| Sep 30, 2025 | 80.50 Mn |
| Jun 30, 2025 | 94.10 Mn |
| Jun 30, 2025 | 94.10 Mn |
| Mar 31, 2025 | 87.00 Mn |
| Mar 31, 2025 | 87.00 Mn |
| Dec 31, 2024 | 124.60 Mn |
| Dec 31, 2024 | 124.60 Mn |
| Sep 30, 2024 | 111.20 Mn |
| Sep 30, 2024 | 111.20 Mn |
| Jun 30, 2024 | 66.10 Mn |
| Jun 30, 2024 | 66.10 Mn |
| Mar 31, 2024 | 56.90 Mn |
| Mar 31, 2024 | 56.90 Mn |